Immunotec’s Scientific Advisory Board (SAB)
Immunotec’s Scientific Advisory Board (SAB) is a respected team of experts dedicated to providing high quality and scientifically proven products. The SAB developed standards of evidence based on the pre-clinical and clinical studies conducted to standardize the health and wellness we offer our Customers. In addition, they represent Immunotec publicly while focusing on the regulatory decisions made in Canada, the United States, and Mexico.
Dr. Jimmy Gutman
MD Chief Scientific Officer
Chairman of the Scientific Advisory Board for Immunotec
Board of Directors for the Canadian Association of Emergency Medicine
The author of several best-selling books on glutathione, Dr. Jimmy Gutman is arguably the world’s preeminent expert on the role of this critical substance in human health. His expert knowledge has been invaluable in bringing public awareness to bridging the gap between traditional and complementary medicine.
Dr. Gutman’s latest book, The Comprehensive Guide to Glutathione is considered the seminal work on glutathione research and clinical applications. Dr. Gutman taught at McGill University Medical School where his original specialty was academic emergency medicine. He was trained at the University of Calgary and did his specialty training at Emory University in Atlanta, Georgia, where he was chief resident. Dr. Gutman served on the Board of Directors for the Canadian Association of Emergency Medicine, and numerous other boards dealing with policy and education. Dr. Gutman has been a scientific advisor to Immunotec for more than 25 years and continues to make strides forward in glutathione research.
“This is the most important natural health product you will ever use.”
Dr. Patricia Kongshavn M.Sc., Ph.D.
Honorary Lifetime Member and Co-Founder of Immunocal
Member of the Faculty of Medicine at McGill University
Dr. Patricia Kongshavn was an early pioneer in the emerging field of basic immunology. Her collaboration with Dr Gustavo Bounous resulted in joint research investigating using dietary proteins to improve the immune response. Their work led to the discovery of a whey protein concentrate that enhanced immune responsiveness by raising glutathione levels and the eventual formation of Immunotec as one of the first health-tech companies in the world.
Dr. Kongshavn received her honors degree in Natural Sciences at Cambridge University. She completed her master’s in Physiology and her doctoral degree in Immunology at McGill University. She was a Full Professor in the Department of Medicine at McGill University until her retirement. She has continued as a highly valued advisor to Immunotec.
“Immunocal is a natural source for the maintenance of a strong immune system.”
Co-Founder of Immunotec
Honorary Lifetime Member of Immunotec’s Scientific Advisory Board
A co-founder of Immunotec, John Molson has been responsible for securing high-level research partners for clinical and scientific studies. John has contributed to more than 30 medical publications and four patent applications. John is also an elite athlete, having won multiple cycling and triathlon championships. He currently holds the title of Research Ambassador for Immunotec.
Dr. Nathan Lewis
Member of the Scientific Advisory Board for Immunotec
Lead Performance and Clinical Nutrition Scientist for ORRECO
Lead Performance Nutrition Scientist at Institute of Sport (EIS)
Research fellow at St. Mary’s University
An expert in the area of athletic performance, Dr. Nathan Lewis specializes in biomarkers, oxidative stress in elite endurance athletes, and Overtraining Syndrome. Dr. Lewis is the Lead Performance Nutrition Scientist for the English Institute of Sport, having worked as a senior performance nutritionist across four Olympics.
In addition, Dr. Lewis has extensive experience consulting to professional sports teams in the English Premier League, PGA, NBA, NHL, and MLB through his role as the Lead Performance and Clinical Nutritionist and Biomarker Scientist at the sports science and data/biomarker analytics company ORRECO. He is also a research fellow at St Mary’s University
Dr. Dan Linseman
Professor of Neuropharmacology and Cell Signaling, University of Denver
Member of Scientific Advisory Board
A professor at University of Denver, Dr. Dan Linseman teaches Neuropharmacology and Cell Signaling. He received his B.S. in Biology and Chemistry his Ph.D. in Pharmacology from the University of Michigan. Dr. Linseman studies the impact of oxidative stress, the role of antioxidants, anti-neuroinflammatory, and neuroprotective properties in a variety of natural products, including Immunocal. He conducts research on neurotrauma, neurodegeneration, and neurophysiology, and is one the preeminent experts on Lou Gehrig’s disease.
His research is focused on neurotrauma, neurodegeneration and neurophysiology with an emphasis on Lou Gehrig’s disease, Alzheimer’s disease, and traumatic brain injury.
Dr. Linseman studies the impact of oxidative stress, the role of antioxidants, anti-neuroinflammatory, and neuroprotective properties in a variety of natural products, including Immunocal.